Alzheimer’s
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use – Associated Press
Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance
MATTHEW PERRONE | AP Health Writer
June 10, 2023
